EP1446167A2 - Traitement d'aphtes au moyen de patchs permettant de guerir et de soulager la douleur rapidement - Google Patents
Traitement d'aphtes au moyen de patchs permettant de guerir et de soulager la douleur rapidementInfo
- Publication number
- EP1446167A2 EP1446167A2 EP02791205A EP02791205A EP1446167A2 EP 1446167 A2 EP1446167 A2 EP 1446167A2 EP 02791205 A EP02791205 A EP 02791205A EP 02791205 A EP02791205 A EP 02791205A EP 1446167 A2 EP1446167 A2 EP 1446167A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- gum
- medication
- patch
- patches
- dgl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000002399 aphthous stomatitis Diseases 0.000 title claims abstract description 43
- 208000002193 Pain Diseases 0.000 title claims abstract description 23
- 230000035876 healing Effects 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 claims abstract description 55
- 239000003814 drug Substances 0.000 claims abstract description 53
- 229940079593 drug Drugs 0.000 claims abstract description 52
- 208000020670 canker sore Diseases 0.000 claims abstract description 29
- 210000003296 saliva Anatomy 0.000 claims abstract description 27
- 229960003022 amoxicillin Drugs 0.000 claims abstract description 10
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 claims abstract description 10
- 239000004599 antimicrobial Substances 0.000 claims abstract description 10
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229930182555 Penicillin Natural products 0.000 claims abstract description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims abstract description 5
- 229940049954 penicillin Drugs 0.000 claims abstract description 5
- 239000011230 binding agent Substances 0.000 claims description 21
- 239000004615 ingredient Substances 0.000 claims description 18
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 14
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 235000017443 Hedysarum boreale Nutrition 0.000 claims description 12
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims description 12
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims description 12
- 229920002752 Konjac Polymers 0.000 claims description 10
- 230000000845 anti-microbial effect Effects 0.000 claims description 10
- 239000000252 konjac Substances 0.000 claims description 10
- 235000019823 konjac gum Nutrition 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 229920000161 Locust bean gum Polymers 0.000 claims description 9
- 239000003242 anti bacterial agent Substances 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- 235000010420 locust bean gum Nutrition 0.000 claims description 9
- 239000000711 locust bean gum Substances 0.000 claims description 9
- 239000000230 xanthan gum Substances 0.000 claims description 9
- 235000010493 xanthan gum Nutrition 0.000 claims description 9
- 229920001285 xanthan gum Polymers 0.000 claims description 9
- 229940082509 xanthan gum Drugs 0.000 claims description 9
- 241000241413 Propolis Species 0.000 claims description 7
- 229940069949 propolis Drugs 0.000 claims description 7
- 230000000844 anti-bacterial effect Effects 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 4
- 244000215068 Acacia senegal Species 0.000 claims description 3
- 229920001817 Agar Polymers 0.000 claims description 3
- 229920000084 Gum arabic Polymers 0.000 claims description 3
- 235000010489 acacia gum Nutrition 0.000 claims description 3
- 239000000205 acacia gum Substances 0.000 claims description 3
- 239000008272 agar Substances 0.000 claims description 3
- 235000010419 agar Nutrition 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical group [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 235000012054 meals Nutrition 0.000 abstract description 6
- SGRYPYWGNKJSDL-UHFFFAOYSA-N amlexanox Chemical compound NC1=C(C(O)=O)C=C2C(=O)C3=CC(C(C)C)=CC=C3OC2=N1 SGRYPYWGNKJSDL-UHFFFAOYSA-N 0.000 abstract description 4
- 229960003731 amlexanox Drugs 0.000 abstract description 4
- 238000002483 medication Methods 0.000 abstract description 2
- 229940069445 licorice extract Drugs 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 11
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 239000007788 liquid Substances 0.000 description 8
- 208000007107 Stomach Ulcer Diseases 0.000 description 7
- 208000025865 Ulcer Diseases 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000000499 gel Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000007937 lozenge Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 4
- 230000001387 anti-histamine Effects 0.000 description 4
- 239000000739 antihistaminic agent Substances 0.000 description 4
- 210000003608 fece Anatomy 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 2
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 2
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 2
- 241000590002 Helicobacter pylori Species 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 229940099112 cornstarch Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000000416 hydrocolloid Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940010454 licorice Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229940100692 oral suspension Drugs 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 240000004760 Pimpinella anisum Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940078916 carbamide peroxide Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 229960002163 hydrogen peroxide Drugs 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Definitions
- an oral patch as used herein and other forms of medicinal preparations is that an oral patch is designed to release medication into the mouth over a relatively long period of time, such as 30 minutes or more, restrict local flow of saliva so that the medication can reach high concentrations along side the patch, and remain in the mouth as a single item that will not spread to be in a plurality of locations in the mouth at one time.
- the mixture is deposited as an array of hot, viscous drops onto a sheet of high temperature plastic or coated paper.
- the drops are allowed to cool and then the sheets of plastic or coated paper with the drops on them are dried in a drying room or oven till the water activity level less than 0.8.
- the product is sold still adhered to the plastic or paper and the user pulls it off the plastic or paper.
- Pain relief Using a DGL patch for 10-15 minutes before a meal relieves pain of the canker sore, and, if used up to commencement of a meal, the pain relief lasts through a typical meal. There is no numbing effect on surrounding tissues.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Insects & Arthropods (AREA)
- Anesthesiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Animal Husbandry (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10192668A EP2338475A3 (fr) | 2001-11-05 | 2002-11-05 | Traitement d'aphtes au moyen de patchs permettant de guérir et de soulager la douleur rapidement |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33291601P | 2001-11-05 | 2001-11-05 | |
| US332916P | 2001-11-05 | ||
| US34457701P | 2001-12-28 | 2001-12-28 | |
| US344577P | 2001-12-28 | ||
| US23628902A | 2002-09-04 | 2002-09-04 | |
| US236289 | 2002-09-04 | ||
| PCT/US2002/035399 WO2003039465A2 (fr) | 2001-11-05 | 2002-11-05 | Traitement d'aphtes au moyen de patchs permettant de guerir et de soulager la douleur rapidement |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1446167A2 true EP1446167A2 (fr) | 2004-08-18 |
| EP1446167A4 EP1446167A4 (fr) | 2010-09-29 |
Family
ID=27398834
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP10192668A Withdrawn EP2338475A3 (fr) | 2001-11-05 | 2002-11-05 | Traitement d'aphtes au moyen de patchs permettant de guérir et de soulager la douleur rapidement |
| EP02791205A Withdrawn EP1446167A4 (fr) | 2001-11-05 | 2002-11-05 | Traitement d'aphtes au moyen de patchs permettant de guerir et de soulager la douleur rapidement |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP10192668A Withdrawn EP2338475A3 (fr) | 2001-11-05 | 2002-11-05 | Traitement d'aphtes au moyen de patchs permettant de guérir et de soulager la douleur rapidement |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP2338475A3 (fr) |
| JP (2) | JP2005508980A (fr) |
| CN (1) | CN1309425C (fr) |
| AU (2) | AU2009217365A1 (fr) |
| CA (1) | CA2466061A1 (fr) |
| WO (1) | WO2003039465A2 (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107802641A (zh) * | 2016-09-09 | 2018-03-16 | 李明典 | 口腔软组织(牙龈、粘膜)抗发炎酸痛剂 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7201930B2 (en) | 2001-11-05 | 2007-04-10 | Haley Jeffrey T | Licorice root extract oral patch for treating canker sores |
| CN1309425C (zh) * | 2001-11-05 | 2007-04-11 | 奥拉黑尔斯公司 | 用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法 |
| JP2006096728A (ja) * | 2004-09-30 | 2006-04-13 | Kobayashi Pharmaceut Co Ltd | 口腔内定着型固形製剤 |
| US20070243238A1 (en) * | 2006-04-13 | 2007-10-18 | Haley Jeffrey T | Treating mouth sores with patches adhered to teeth |
| CN1850059B (zh) * | 2006-05-29 | 2010-05-12 | 王法平 | 氨来呫诺口腔膜剂及其制备方法 |
| CN101138541B (zh) * | 2006-09-06 | 2010-10-06 | 上海医药工业研究院 | 氨来占诺局部成膜凝胶组合物及其应用 |
| EP1917982B1 (fr) * | 2006-11-06 | 2010-04-21 | Lohmann & Rauscher GmbH & Co. KG | Produit de traitement de l'inflammation, les contusions et/ou les aphtes pour les soins buccaux et utilisation d'un tel produit |
| JP2008208088A (ja) * | 2007-02-27 | 2008-09-11 | Ehime Univ | 口内炎処置用組成物 |
| EP3673902B1 (fr) * | 2012-02-19 | 2022-01-05 | Quest Products, LLC | Adhésif de gomme d'acacia alcalinisé pour disques d'adhérence orale |
| US20150320676A1 (en) * | 2012-12-13 | 2015-11-12 | Lts Lohmann Therapie-Systeme Ag | Topical drug for treating aphthae |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3046195A (en) | 1957-03-14 | 1962-07-24 | Gerardus Van Loon | Process for deglycyrrhizinating licorice |
| IL65184A0 (en) * | 1982-03-05 | 1982-05-31 | Yissum Res Dev Co | Preparation for the treatment of oral diseases,comprising glycyrrhizin |
| US5362737A (en) * | 1991-04-09 | 1994-11-08 | Chemex Pharmaceuticals, Inc. | Methods of treating aphthous ulcers and other mucocutaneous disorders with amlexanox |
| JP2609564B2 (ja) * | 1991-05-31 | 1997-05-14 | 政夫 斎藤 | アレルギー性皮膚炎用クリーム及びその製造方法 |
| US5198217A (en) * | 1991-09-24 | 1993-03-30 | Choice Pharmaceuticals | Topical demulcent for viral and inflammatory diseases of the skin |
| JP3350678B2 (ja) * | 1992-02-27 | 2002-11-25 | 株式会社ダイゾー | 口腔用エアゾール製品 |
| US5409703A (en) * | 1993-06-24 | 1995-04-25 | Carrington Laboratories, Inc. | Dried hydrogel from hydrophilic-hygroscopic polymer |
| US5713852A (en) * | 1995-06-07 | 1998-02-03 | Alza Corporation | Oral dosage and method for treating painful conditions of the oral cavity |
| US5849322A (en) * | 1995-10-23 | 1998-12-15 | Theratech, Inc. | Compositions and methods for buccal delivery of pharmaceutical agents |
| TW452494B (en) * | 1996-03-12 | 2001-09-01 | Jang De Shan | Herbal composition for stimulating blood circulation |
| BR9811478A (pt) * | 1997-07-23 | 2000-08-15 | Perio Prod Ltd | Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral |
| JPH11197217A (ja) * | 1998-01-12 | 1999-07-27 | Kanae Kagawa:Kk | 速溶性ディスポ口腔用材 |
| US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
| US6248718B1 (en) | 1999-08-18 | 2001-06-19 | Atlantic Biomed Corporation | Lesion-directed dry dosage forms of antibacterial agents for the treatment of acute mucosal infections of the oral cavity |
| JP2001089346A (ja) * | 1999-09-24 | 2001-04-03 | We'll Corporation:Kk | 口腔用組成物 |
| DE10038571A1 (de) * | 2000-08-03 | 2002-02-14 | Knoll Ag | Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen |
| CN1309425C (zh) * | 2001-11-05 | 2007-04-11 | 奥拉黑尔斯公司 | 用贴片治疗口腔溃疡以加速痊愈和缓解疼痛的方法 |
| US20070048369A1 (en) * | 2005-08-26 | 2007-03-01 | National Starch And Chemical Investment Holding Corporation | Mucosal delivery tablet |
-
2002
- 2002-11-05 CN CNB028220641A patent/CN1309425C/zh not_active Expired - Fee Related
- 2002-11-05 WO PCT/US2002/035399 patent/WO2003039465A2/fr not_active Ceased
- 2002-11-05 JP JP2003541757A patent/JP2005508980A/ja active Pending
- 2002-11-05 EP EP10192668A patent/EP2338475A3/fr not_active Withdrawn
- 2002-11-05 EP EP02791205A patent/EP1446167A4/fr not_active Withdrawn
- 2002-11-05 CA CA002466061A patent/CA2466061A1/fr not_active Abandoned
-
2009
- 2009-09-17 AU AU2009217365A patent/AU2009217365A1/en not_active Abandoned
- 2009-09-17 AU AU2009217366A patent/AU2009217366A1/en not_active Abandoned
-
2010
- 2010-03-12 JP JP2010055534A patent/JP2010163451A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107802641A (zh) * | 2016-09-09 | 2018-03-16 | 李明典 | 口腔软组织(牙龈、粘膜)抗发炎酸痛剂 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2466061A1 (fr) | 2003-05-15 |
| JP2005508980A (ja) | 2005-04-07 |
| AU2009217365A1 (en) | 2009-10-08 |
| WO2003039465A2 (fr) | 2003-05-15 |
| JP2010163451A (ja) | 2010-07-29 |
| EP2338475A2 (fr) | 2011-06-29 |
| CN1582172A (zh) | 2005-02-16 |
| EP1446167A4 (fr) | 2010-09-29 |
| AU2009217366A1 (en) | 2009-10-08 |
| CN1309425C (zh) | 2007-04-11 |
| EP2338475A3 (fr) | 2012-08-08 |
| WO2003039465A3 (fr) | 2003-11-20 |
| HK1073802A1 (en) | 2005-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009217366A1 (en) | Treating canker sores with patches to speed healing and relieve pain | |
| ES2217000T3 (es) | Apositos medicos que comprenden miel gelificada. | |
| US20040156930A1 (en) | Treating mouth ulcers with patches to speed healing and relieve pain | |
| WO2020051048A1 (fr) | Compositions de cannabinoïdes et de menthol et procédés associés | |
| US20210000759A1 (en) | Cannabinoid and menthol compositions and methods | |
| JPH059412B2 (fr) | ||
| EP2012768B1 (fr) | Pastille concave, érodable et adhésive pour l'application orale | |
| WO2002098464A2 (fr) | Composition polymere liquide destinee a la prevention et au traitement des affections de la cavite buccale | |
| WO2021177937A1 (fr) | Compositions à base de cannabinoïdes et de menthol et procédés associés | |
| JP2005508980A5 (fr) | ||
| US10966924B2 (en) | Veterinary cannabinoid, menthol and anesthetic compositions and methods | |
| US8945606B2 (en) | Oral adhering disc with dimple on adhering side | |
| WO2020051047A2 (fr) | Compositions et procédés faisant appel à des cannabinoïdes et à des anesthésiques | |
| US20150110851A1 (en) | Oral adhering patch with dimple on adhering side | |
| US20210220292A1 (en) | Cannabinoid and anesthetic compositions and methods | |
| WO2006119474A2 (fr) | Procedes et dispositifs permettant de traiter efficacement des ulceres aphteux | |
| NO328979B1 (no) | Anvendelse av diklorbenzylalkohol for fremstilling av et preparat for topisk behandling av inflammasjon | |
| AU2002363325A1 (en) | Treating canker sores with patches to speed healing and relieve pain | |
| US10813963B2 (en) | Veterinary cannabinoid and menthol compositions and methods | |
| HK1073802B (en) | Treating canker sores with patches to speed healing and relieve pain | |
| US11344495B2 (en) | Veterinary cannabinoid, menthol and anesthetic compositions and methods | |
| RU2400231C2 (ru) | СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЙ ЖЕЛУДКА И ДВЕНАДЦАТИПЕРСТНОЙ КИШКИ, ВЫЗВАННЫХ Helicobacter pylori, СОВМЕСТНО С ПРОВЕДЕНИЕМ ЛЕЧЕБНЫХ МЕРОПРИЯТИЙ В ПОЛОСТИ РТА | |
| WO2004000253A1 (fr) | Formulations dentaires pharmaceutiques ameliorees | |
| WO2021177936A1 (fr) | Compositions de cannabinoïdes et d'anesthésiques et procédés associés | |
| CN101066257A (zh) | 用于治疗口腔溃疡的甘草根提取物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040601 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20100831 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 1/02 20060101ALI20100823BHEP Ipc: A61K 9/00 20060101AFI20100823BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20101130 |